Ligand validation:6AVL

XYP: beta-D-xylopyranose

XYP is a Ligand Of Interest in 6AVL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AVL_XYP_A_304	50%	43%	0.109	0.856	1.54	0.68	2	-	0	0	100%	0.81
6B6P_XYP_A_305	55%	31%	0.097	0.864	1.31	1.44	1	3	0	0	100%	1
6B6Q_XYP_A_305	50%	38%	0.1	0.848	1.38	1.05	1	-	0	0	100%	1
6B6O_XYP_A_305	4%	30%	0.222	0.605	1.92	0.88	3	-	0	0	100%	1
1OD8_XYP_A_1311	100%	64%	0.047	0.992	0.75	0.64	-	-	0	0	100%	1
1V0M_XYP_A_1304	100%	71%	0.035	0.993	0.82	0.33	-	-	0	0	90%	0.9
8Y00_XYP_D_201	99%	28%	0.032	0.986	0.63	2.19	-	7	1	0	90%	0.9
2WYS_XYP_A_1001	99%	38%	0.052	0.983	0.69	1.7	-	4	3	0	100%	1
1V0N_XYP_A_1306	98%	60%	0.048	0.989	0.76	0.78	-	-	0	0	90%	0.9

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.